What We're Reading: Page 374
Industry reads hand-picked by our editors
Apr 14, 2015
Apr 13, 2015
-
Seeking Alpha
AstraZeneca strikes pact with PatientsLikeMe to get patient input on meds
-
WSJ
India threatens official complaints on behalf of CRO
-
Reuters
FDA staff recommends previously rejected Medicines Co blood clot preventer
-
In-Pharmatechnologist
Novo builds new insulin manufacturing facility in Russia
Apr 10, 2015
Apr 09, 2015
-
NYT
Merck, Glaxo Ebola vaccines showing plenty of promise
-
FierceBiotech
Bad news for Shire as rare liver disease drug flops in Phase II
-
Law360
Judge chides FDA for stalling Otsuka's Abilify lawsuit
-
Reuters
CA bill banning childhood vax exemptions moves forward
-
Pharma Times
EU OKs Roche's Avastin for advanced cervical cancer
Apr 08, 2015
-
Reuters
FDA accepts Novo's resubmission for insulin Tresiba
-
SF Business Journal
Next-gen, low-dose Gilead HIV drug heads to FDA
-
The Pink Sheet (gated)
Biosimilar costs could exceed brands' prices in Medicare Part D
-
In-Pharmatechnologist
Indian pharma and French regulators lock horns over med suspensions
Apr 07, 2015
Apr 06, 2015
-
Seeking Alpha
Alkermes antipsychotic shows promise in phase II
-
In-Pharmatechnologist
Sanofi R&D chief slams pharma's fixation with super specialty meds
-
Pharma Times
Pfizer, Bind Therapeutics extend Accurins alliance
Previous
